Ulinastatin
Ulinastatin is a pharmaceutical drug with 28 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
92.9%
13 of 14 finished
7.1%
1 ended early
0
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass
Clinical Trials (28)
Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Ulinastatin Treatment Reduces the Incidence of Sepsis-associated Encephalopathy
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass
Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)
Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction
Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS)
Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality
Effect of Ulinastatin on the Action of NDMRs (Rocuronium / Cisatracurium)
Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China
Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome
Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients
Effects of Ulinastatin on Inflammatory Response During ECMO Support
The Effect of Ulistin on Acute Renal Injury in Patients Undergoing OPCAB (Off Pump Coronary Artery Bypass): a Propensity Score Matched Study
Protective Effect in Cardiac Surgery Patients
Hemostatic Effects of Ulinastatin and Tranexamic Acid in Cardiac Surgery
Post-market Safety Reassessment of Ulinastatin for Injection
The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)
Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 28